whether patients should undergo genetic testing to determine their warfarin dose

October 2007

Experts are now debating whether patients should undergo genetic testing to determine their warfarin dose.

Most clinicians titrate warfarin doses by trial and error.

Now the FDA is suggesting lower doses for patients with certain genetic variations.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote